Related Experiment Video
Updated: Jul 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The TGFbeta/Smad 3-signaling pathway is involved in butyrate-mediated vitamin D receptor (VDR)-expression
Carolin Daniel1, Oliver Schroder, Nadine Zahn
1First Department of Internal Medicine, ZAFES, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Abstract:
Previously, we demonstrated the pivotal role of the vitamin D receptor (VDR) in mediating the butyrate-induced differentiation in colon cancer cells. Smad 3, a downstream component of transforming growth factor-beta (TGFbeta) signaling, has been shown to act as a coactivator of VDR and to possibly regulate the vitamin D signaling pathway. In this study, we demonstrate a distinct impact of the TGFbeta/Smad 3-signaling pathway in the butyrate-mediated VDR expression and induction of differentiation. Butyrate treatment resulted in a significant induction of the phosphorylation level of Smad 3, while the combination of butyrate and a specific TGFbeta1-antibody or a TGFbeta-receptor inhibitor considerably diminished the butyrate-induced upregulation of VDR expression. Using a specific inhibitor, we were also able to demonstrate an involvement of the p38 MAPK in the increase of Smad 3 phosphorylation following butyrate treatment, thus opening the view to further elucidate possible mechanisms mediating the upregulation of VDR expression following butyrate treatment in colon cancer cells.
Insights
Butyrate enhances colon cancer cell differentiation by upregulating vitamin D receptor (VDR) expression. This process involves the transforming growth factor-beta (TGFbeta)/Smad 3 pathway and p38 MAPK, crucial for VDR regulation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The vitamin D receptor (VDR) is crucial for butyrate-induced differentiation in colon cancer cells.
- Smad 3, a transforming growth factor-beta (TGFbeta) signaling component, acts as a VDR coactivator.
Purpose of the Study:
- To investigate the role of the TGFbeta/Smad 3 pathway in butyrate-mediated VDR expression and colon cancer cell differentiation.
- To elucidate the mechanisms underlying VDR upregulation by butyrate.
Main Methods:
- Butyrate treatment of colon cancer cells.
- Analysis of Smad 3 phosphorylation levels.
- Inhibition of TGFbeta signaling using antibodies and receptor inhibitors.
- Assessment of VDR expression.
- Inhibition of p38 MAPK activity.
Main Results:
- Butyrate treatment significantly increased Smad 3 phosphorylation.
- Inhibiting TGFbeta signaling diminished butyrate-induced VDR upregulation.
- p38 MAPK was involved in the increase of Smad 3 phosphorylation induced by butyrate.
Conclusions:
- The TGFbeta/Smad 3 pathway distinctly impacts butyrate-mediated VDR expression and colon cancer cell differentiation.
- p38 MAPK plays a role in mediating VDR upregulation by butyrate in colon cancer cells.
Related Concept Videos
TGF - β Signaling Pathway
Dysbiosis of the Gut Microbiota
Non-Canonical Wnt Signaling Pathways
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Functions of the Gut Microbiota

